New asthma drug shows promise in early safety trial
NCT ID NCT04007198
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tested a drug called itolizumab (EQ001) in 18 adults with moderate-to-severe asthma that is not well controlled by standard treatments. The main goal was to see if the drug is safe and how the body processes it. Researchers also looked for early signs that it might help control asthma symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Itolizumab (EQ001), a drug given by infusion
What this could lead to
If it works, this could point toward a new treatment option for people with hard-to-control asthma.
What could go wrong
This is a very early, small Phase 1 trial with only 18 people. It mainly checks safety, not whether the drug actually helps asthma. Many early-stage drugs fail to show benefit in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Box Hill Hospital
Box Hill, Australia
-
Dunedin Hospital
Dunedin, New Zealand
-
Flinders Medical Centre
Adelaide, Australia
-
Medical Research Institute of New Zealand
Wellington, New Zealand
-
Melbourne Health
Parkville, Australia
-
Monash Medical Centre
Clayton, Australia
-
Paratus Clinical Research Central Coast
Kanwal, Australia
-
Paratus Clinical Research Western Sydney
Sydney, Australia
-
Respiratory Clinical Trials
Kent Town, Australia
-
Respiratory Research, Greenland Clinical Centre
Auckland, New Zealand
-
The New Zealand Respiratory & Sleep Institute
Greenlane, New Zealand
-
The Queen Elizabeth Hospital
Woodville, Australia
-
TrialsWest
Murdoch, Australia